Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ET2S
|
|||
Former ID |
DIB009838
|
|||
Drug Name |
Epetirimod
|
|||
Synonyms |
Epetirimod esylate; Immunomodulator, Takeda; R-851; S-30563; TAK-851; HPV/cervical dysplasia therapy, Takeda; Immunomodulator, 3M/Takeda; HPV/cervical dysplasia therapy, 3M/Takeda; S-30563-35-65; 851A; 851B; 851B gel
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 2 | [1] | |
Company |
Takeda Chemical Industries
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H15N5
|
|||
Canonical SMILES |
CC(C)CN1C=NC2=C1C3=C(C=CC=N3)N=C2N
|
|||
InChI |
1S/C13H15N5/c1-8(2)6-18-7-16-11-12(18)10-9(17-13(11)14)4-3-5-15-10/h3-5,7-8H,6H2,1-2H3,(H2,14,17)
|
|||
InChIKey |
UCPMSMNKGXUFCC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 227318-71-0
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00312286) Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.